Source:http://linkedlifedata.com/resource/pubmed/id/17465232
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2007-4-30
|
| pubmed:abstractText |
The Fas receptor is known to be widely expressed in various tissues and FasL is highly expressed on cells of the immune system and also on cells of immune-privileged areas such as the eyes and brain. Ovarian cells are known to exhibit marked FasL immunoreactivity throughout follicular development; there may also be a relationship between Fas and FasL polymorphisms and the immune privileges of the epithelial ovarian cells.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0250-7005
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
27
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
991-4
|
| pubmed:dateRevised |
2007-6-19
|
| pubmed:meshHeading |
pubmed-meshheading:17465232-Adult,
pubmed-meshheading:17465232-Alleles,
pubmed-meshheading:17465232-Antigens, CD95,
pubmed-meshheading:17465232-Epithelial Cells,
pubmed-meshheading:17465232-Fas Ligand Protein,
pubmed-meshheading:17465232-Female,
pubmed-meshheading:17465232-Genotype,
pubmed-meshheading:17465232-Humans,
pubmed-meshheading:17465232-Middle Aged,
pubmed-meshheading:17465232-Ovarian Neoplasms,
pubmed-meshheading:17465232-Polymorphism, Single Nucleotide
|
| pubmed:articleTitle |
Fas-1377A/G and FasL-844 T/C gene polymorphisms and epithelial ovarian cancer.
|
| pubmed:affiliation |
Istanbul University, Institute for Experimental Medical Research, Department of Molecular Medicine, Capa, Istanbul, Turkey.
|
| pubmed:publicationType |
Journal Article
|